Literature DB >> 11959986

The frameshift signal of HIV-1 involves a potential intramolecular triplex RNA structure.

Jonathan D Dinman1, Sara Richter, Ewan P Plant, Ronald C Taylor, Amy B Hammell, Tariq M Rana.   

Abstract

The cis-acting mRNA elements that promote programmed -1 ribosomal frameshifting present a natural target for the rational design of antiretroviral chemotherapies. It has been commonly accepted that the HIV-1 frameshifting signal is special, because its downstream enhancer element consists of a simple mRNA stem loop rather than a more complex secondary structure such as a pseudoknot. Here we present three lines of evidence, bioinformatic, structural, and genetic, showing that the biologically relevant HIV-1 frameshift signal contains a complex RNA structure that likely includes an extended RNA triple-helix region. We suggest that the potential intramolecular triplex structure is essential for viral propagation and viability, and that small molecules targeted to this RNA structure may possess antiretroviral activities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959986      PMCID: PMC122769          DOI: 10.1073/pnas.082102199

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Ribosomal movement impeded at a pseudoknot required for frameshifting.

Authors:  C Tu; T H Tzeng; J A Bruenn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Ribosomal frameshifting efficiency and gag/gag-pol ratio are critical for yeast M1 double-stranded RNA virus propagation.

Authors:  J D Dinman; R B Wickner
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Poly(rA) binds poly(rG).poly(rC) to form a triple helix.

Authors:  M Chastain; I Tinoco
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

4.  Identification of putative programmed -1 ribosomal frameshift signals in large DNA databases.

Authors:  A B Hammell; R C Taylor; S W Peltz; J D Dinman
Journal:  Genome Res       Date:  1999-05       Impact factor: 9.043

5.  Conformation of the TAR RNA-arginine complex by NMR spectroscopy.

Authors:  J D Puglisi; R Tan; B J Calnan; A D Frankel; J R Williamson
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

7.  Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo.

Authors:  N T Parkin; M Chamorro; H E Varmus
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

8.  Mutagenesis of the Glu-89 residue in human immunodeficiency virus type 1 (HIV-1) and HIV-2 reverse transcriptases: effects on nucleoside analog resistance.

Authors:  Q Song; G Yang; S P Goff; V R Prasad
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Ribosomal pausing during translation of an RNA pseudoknot.

Authors:  P Somogyi; A J Jenner; I Brierley; S C Inglis
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

10.  Mutational analysis of the "slippery-sequence" component of a coronavirus ribosomal frameshifting signal.

Authors:  I Brierley; A J Jenner; S C Inglis
Journal:  J Mol Biol       Date:  1992-09-20       Impact factor: 5.469

View more
  40 in total

1.  Exploring the repertoire of RNA secondary motifs using graph theory; implications for RNA design.

Authors:  Hin Hark Gan; Samuela Pasquali; Tamar Schlick
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

Review 2.  The 9-A solution: how mRNA pseudoknots promote efficient programmed -1 ribosomal frameshifting.

Authors:  Ewan P Plant; Kristi L Muldoon Jacobs; Jason W Harger; Arturas Meskauskas; Jonathan L Jacobs; Jennifer L Baxter; Alexey N Petrov; Jonathan D Dinman
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

3.  Solution structure of the HIV-1 frameshift inducing stem-loop RNA.

Authors:  David W Staple; Samuel E Butcher
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

4.  A -1 ribosomal frameshift element that requires base pairing across four kilobases suggests a mechanism of regulating ribosome and replicase traffic on a viral RNA.

Authors:  Jennifer K Barry; W Allen Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

5.  Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M.

Authors:  Martin Baril; Dominic Dulude; Karine Gendron; Guy Lemay; Léa Brakier-Gingras
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

6.  Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients.

Authors:  Lucile Larrouy; C Chazallon; R Landman; C Capitant; G Peytavin; G Collin; C Charpentier; A Storto; G Pialoux; C Katlama; P M Girard; P Yeni; J P Aboulker; F Brun-Vezinet; D Descamps
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

7.  Characterization of RNA elements that regulate gag-pol ribosomal frameshifting in equine infectious anemia virus.

Authors:  Chaoping Chen; Ronald C Montelaro
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  A complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replication.

Authors:  Byung-Hak Song; Sang-Im Yun; Yu-Jeong Choi; Jeong-Min Kim; Chan-Hee Lee; Young-Min Lee
Journal:  RNA       Date:  2008-07-30       Impact factor: 4.942

9.  Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides.

Authors:  Michael T Howard; Raymond F Gesteland; John F Atkins
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

10.  An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae.

Authors:  Jason W Harger; Jonathan D Dinman
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.